Introduction
pmol ATP (7 µCi [g-32 P]ATP, 3000 Ci/mmol). The reaction was carried out at pH 9.6.
Tamoxifen is a nonsteroidal antiestrogen successfully used in
For HPLC analysis the mixtures were diluted to 20 µl with water, and the adjuvant therapy of breast cancer since the 1970s. It has been whole sample was injected into the Beckman HPLC system Gold, used with estimated that recurrence of breast cancer is decreased by 40% a Phenomenex Kromasil C18 (2ϫ250 mm, particle size 5 µm) column. A due to long-term adjuvant treatment (1) . Several studies are precolumn filter was installed in front of the analytical column. The volume of the sample loop was 20 µl.
currently being carried out in assumed risk populations where Radioactivity was measured on-line with a Beckman 171 Radioisotope tamoxifen is used prophylactically. Tamoxifen has been shown detector. The size of the teflon sample loop in the flow cell was 75/100 µl, to cause liver cancer (2-5) and DNA adducts in several which was then folded into a scintillation tube containing scintillation liquid organs in experimental animals (6-10) and cultured human (Ready Safe, Beckman) . The adducts were quantified by integration of the lymphocytes and human microsomes in vitro (11-13). Endopeak area with subtraction of background radioactivity.
Separations were carried out at ambient temperature using a binary gradient metrial cancer and other serious side-effects of therapy have with methanol and 0.2 M ammonium formate (pH 5.4) adjusted to pH 4.2 been reported in tamoxifen-treated patients (1, (14) (15) (16) livers are demonstrated.
Analysis of results

Materials and methods
Adducts levels were calculated from the radioactivity of the samples, background subtracted, assuming 100% recovery and labelling efficiency. As Patients, DNA isolation, rat liver standard these never are 100% (22,23), the 'apparent' adduct levels are underestimates. Blood samples (10 ml) were obtained from 11 breast cancer patients. Of these
In the HPLC analysis the background was obtained from an untreated human six (mean age 72 years) continuously received tamoxifen, 40 mg/day orally, sample, analysed exactly as the other samples. The approximate detection for a minimum of 4 months, and five (mean age 51 years) had not been given limit using such a background definition was 1 adduct/10 9 nucleotides in the HPLC analysis. For evaluation of statistical significance, Student's onesided t-test was used, by considering equality of variance. F-statistics was *Abbreviations: HPLC, high-performance liquid chromatography; TLC, thinlayer chromatography. also applied. humans eluted in two adjacent main peaks, which remained uniform in the mixing experiment, providing further evidence on the identity of the material (Figure 3 ). B). The adduct spot from a control patient 'a1' migrated identically to a faint spot 'b1' from a treated patient. The main Results tamoxifen adduct was 'b2' in Figure 4B . Taken together, the combined HPLC-TLC analysis indicated that true tamoxifen-HPLC analysis was performed using Gradient A and a tamoxifen adduct peak was observed at 56 min ( Figure 1B) . In induced adducts could be identified. Among the 11 patients in the study six had received control samples a small amount of radioactivity was observed at that elution time (Figure1A). These results were reproduced tamoxifen. When analysing coded samples by HPLC, four samples were considered clearly positive and they were all in another gradient system, Gradient B.
When a mixing experiment was carried out by spiking a obtained from the patients who had indeed received the drug. None of the controls were considered positive. The differences liver DNA sample from a tamoxifen-treated rat (Figure 2A ) with an equal radioactivity from a human leucocyte sample of between the tamoxifen-treated patients (5.5 adducts/10 9 ) and the controls (1.9 adducts/10 9 ), analysed by HPLC, are significa tamoxifen-treated patient ( Figure 2B ), a uniform peak was obtained ( Figure 2C ) suggesting that the material is identical.
ant statistically (PϽ0.05, one-sided t-test or F-test). The value for the controls is quite arbitrary because no consistent The spiked human and rat liver samples also showed identical mobility in Gradient B, in which tamoxifen adduct eluted in radioactive peaks were noted in HPLC. The medians and the distribution of individual values is shown in Figure 5 . an isocratic part of the program. The adduct from rats and
Discussion
This is the first report on the identification of tamoxifen-DNA adducts in human leucocytes, matching our recent data on endometrial samples (24). The identification was based initially on blinded HPLC analysis of coded samples. Of 11 patient samples four were considered positive and seven negative using the rat liver adduct as a standard. All the four were indeed treated patients. Thus no false positives but two false negatives were detected. The reason for the two patients being negative for DNA adducts remains unknown.
After opening the code several studies were carried out to confirm the result, including analysis in two HPLC systems, spiking experiments with rat liver DNA samples in two systems and HPLC-TLC analysis in two systems. These data should leave little doubt about identification of true tamoxifen adducts.
The apparent level of leucocyte adducts was 5.5/10 9 nucleotides. In human endometrial samples, analysed by the same technique, the level of adducts was 3/10 9 nucleotides (24). However as the adducts have not been characterised chemically and thus the total recovery of the method cannot be assessed, the present adduct level is most likely an underestimate (22,23). It is indeed an urgent task to characterise the adducts chemically, which would then allow comparisons to other types of adducts. The work on active intermediates and binding sites in DNA facilitates the final characterization (8-14, 25,26). Comparisons between species and extrapolation to carcinogenic potency will also provide important mechanistic data (27, 28) .
In previous work no adducts have been detected in human liver (18), leucocytes (20) nor endometrium (19). The main difference to the present work is that we used HPLC while the others used TLC in the separation of the adducts. Our HPLC method helped to reduce background radioactivity, thus 
